Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
IRVINE, Calif., Nov. 18, 2025 /PRNewswire/ -- Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic...
DNA
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
– Partnership focuses on "kitted" tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially...
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer
More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and...
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and EcuadorBERKELEY, Calif....
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company,...
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S....
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation...
Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a...
AI in Personalized Nutrition Market to Reach USD 4.26 Billion by 2032, Driven by Predictive Analytics, Deep Learning & Real-Time Dietary Intelligence | DataM Intelligence
AUSTIN, Texas and TOKYO, Nov. 17, 2025 /PRNewswire/ -- According to DataM Intelligence, the AI in Personalized Nutrition Market Size reached...
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in...
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
Company to host investor conference call and webcast on Monday, November 17th, at 9:00am ESTPITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE)...
Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update
–Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study...
Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform
BOSTON, Nov. 14, 2025 /PRNewswire/ -- Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned...
New England Biolabs® launches the NEBNext® Flu A Integrated Indexing Primer Module to advance Influenza A surveillance and sequencing
Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms IPSWICH, Mass., Nov. 13, 2025...
Volta Labs Delivers the Ultimate Whole Genome Sequencing Sample Prep Launch: Callisto™ Now Unifies the Entire WGS Ecosystem on One Platform
BOSTON, Nov. 12, 2025 /PRNewswire/ -- Volta Labs, a leader in NGS automation, today announced a major expansion of its...
Carolina Molecular Partners with Pixelgen, Becomes First US Certified Service Provider for Pixelgen Proxiome Kit
Kit offers novel protein interactomics analysis of immune cells MORRISVILLE, N.C. and STOCKHOLM, Nov. 12, 2025 /PRNewswire/ -- Carolina Molecular...
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
SALT LAKE CITY, Nov. 12, 2025 /PRNewswire/ -- Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq:...
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent...
Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results
MIAMI, FL, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic...
2026 Health System AI Governance Resource Guide: Black Book Global Benchmark and Regulatory Readiness Report
First in a Board-Level Series Guiding Hospitals Toward Safe, Equitable, and ROI-Driven AI Deployment SAN ANTONIO, TEXAS / ACCESS Newswire...